CO82 Dupilumab Is Effective in Patients with Atopic Dermatitis and Inadequate Response, Intolerance, or Contraindication to Cyclosporine: A Systematic Review and Meta-Analysis.
Saved in:
| Title: | CO82 Dupilumab Is Effective in Patients with Atopic Dermatitis and Inadequate Response, Intolerance, or Contraindication to Cyclosporine: A Systematic Review and Meta-Analysis. |
|---|---|
| Authors: | Magro, F.J.B.1 (AUTHOR), Oldani, P.A.2 (AUTHOR), Vieira Duarte, G.3 (AUTHOR), Migliavaca, C.B.4 (AUTHOR), Gräf, D.4 (AUTHOR), Schneider, N.5 (AUTHOR), Falavigna, M.4 (AUTHOR), Bosnich, F.1 (AUTHOR), Barbosa, A.1 (AUTHOR), Federico, P.1 (AUTHOR), Taminato, A.1 (AUTHOR), Guyot, P.6 (AUTHOR) |
| Source: | Value in Health. 2023 Supplement, Vol. 26 Issue 6, pS29-S29. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
